(Q40299156)

English

Elevation of radiolabelled thymidine uptake in RIF-1 fibrosarcoma and HT29 colon adenocarcinoma cells after treatment with thymidylate synthase inhibitors

scientific article published on 28 March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Elevation of radiolabelled thymidine uptake in RIF-1 fibrosarcoma and HT29 colon adenocarcinoma cells after treatment with thymidylate synthase inhibitors (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

colon adenocarcinoma

1 reference

based on heuristic

inferred from title

author name string

Kawai Yau

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Patricia Price

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Radhakrishma G Pillai

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Eric Aboagye

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

28 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

981-987

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

https://scigraph.springernature.com/pub.10.1007/s00259-005-0060-8

0 references

Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-0060-8

21 January 2018

Integration of herbal medicine into modern medical practices: issues and prospects

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-0060-8

21 January 2018

Early changes in [18F]FLT uptake after chemotherapy: an experimental study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positron emission tomography imaging of cell proliferation in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical analysis of thymidylate synthase, p16(INK4a), cyclin-dependent kinase 4 and cyclin D1 in colorectal cancers receiving preoperative chemotherapy: significance of p16(INK4a)-mediated cellular arrest as an indicator of chemosensitiv

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinones

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[(18)F]fluoro-3'-deoxythymidine ([(18)F]FLT) in pancreatic cancer cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thymidylate synthase and drug resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positron emission tomography imaging of small animals in anticancer drug development

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

UCN-01 (7-hydroxystaurosporine) inhibits DNA repair and increases cytotoxicity in normal lymphocytes and chronic lymphocytic leukemia lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of de novo and salvage pathways in chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic of DNA-synthesizing enzyme activities (thymidine kinase and thymidylate synthase) in 908 T1-T2, N0-N1, M0 breast cancers: a retrospective multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of elevation of plasma 2'-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2-[11C]thymidine positron emission tomography as an indicator of thymidylate synthase inhibition in patients treated with AG337.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Folate-based thymidylate synthase inhibitors as anticancer drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorouracil: biochemistry and pharmacology

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AG337, a novel lipophilic thymidylate synthase inhibitor: in vitro and in vivo preclinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16568206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-005-0060-8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40299156&oldid=2086403877"